Composition For Treating Brain Lesions

Abstract

The present invention relates to a pharmaceutical composition which includes a biocompatible polymer and a eukaryotic cell to be used as a drug for the prevention and/or treatment of tissue lesions of the central nervous system caused by cerebral vascular ischaemia. The present invention also relates to a pharmaceutical kit which includes a biocompatible polymer and a eukaryotic cell for the prevention and/or treatment of tissue lesions of the central nervous system caused by cerebral vascular ischaemia. The present invention can be used in particular in the human and veterinary pharmaceutical fields.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 1, 2016
  • Application: May 26, 2016
    WO EP 2016061905 W
  • Priority: May 28, 2015
    EP EP 15305806 A

Download Citation


Sign in to the Lens

Feedback